Related Experiment Video
Updated: May 12, 2026
Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
Ependymoma in children: molecular considerations and therapeutic insights
J-H Kim1, Y Huang, A S Griffin
1Department of Neurological Surgery, Weill Cornell Medical College, 525 East 68th Street, Box 99, New York, NY, 10065, USA, jhkim17@gmail.com.
Abstract:
A multi-modality approach that encompasses maximal surgical resection in combination with adjuvant therapy is critical for achieving optimal disease control in children with ependymoma. In view of its complex biology and variable response to therapy, ependymoma remains a challenge for clinicians involved in the care of these patients. Meanwhile, translation of molecular findings can characterize unique features of childhood ependymoma and their natural history. Furthermore, understanding the biology of pediatric ependymoma serves as a platform for development of future targeted therapies. In line with these goals, we review the molecular basis of pediatric ependymoma and its prognostic implications, as well as novel therapeutic advances in the management of ependymoma in children.
Insights
Optimal control of pediatric ependymoma requires maximal surgical resection and adjuvant therapy. Understanding its molecular basis and biology is key to developing targeted therapies for better outcomes in children.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Molecular Biology
Background:
- Ependymoma in children presents complex biological challenges and variable treatment responses.
- Current management relies on a multi-modality approach including maximal surgical resection and adjuvant therapy.
- Significant advancements are needed for improved disease control and patient outcomes.
Purpose of the Study:
- To review the molecular underpinnings of pediatric ependymoma.
- To discuss the prognostic implications of these molecular findings.
- To explore novel therapeutic strategies and advances in managing childhood ependymoma.
Main Methods:
- Comprehensive literature review focusing on molecular biology of pediatric ependymoma.
- Analysis of current therapeutic strategies and their efficacy.
- Integration of molecular findings with clinical management and future therapeutic development.
Main Results:
- Molecular profiling reveals distinct features of childhood ependymoma.
- Specific molecular alterations correlate with disease prognosis and treatment response.
- Emerging targeted therapies show promise for future clinical application.
Conclusions:
- Understanding the molecular basis of pediatric ependymoma is crucial for personalized treatment.
- Translational research is essential for developing novel, targeted therapies.
- Continued investigation into molecular features will improve management and outcomes for children with ependymoma.
